Sight Sciences, Inc.
USPTO PatentsView assignee record - 50 granted patents across 8 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, Sight ranks #6,708 of 49,997 tracked US assignees by granted-patent volume, with 50 patents across 8 technology areas.
- #6,708
- of 49,997 US assignees by volume
- Top 17%
- by Innovation Score (48.3/100)
- 28.0
- avg claims per patent
- +69%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R6708 · US Corporation #6,708 · 50 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL
- GRANTS-SMALL 50 grants
- UPPER-Q #6,708/49,997
- PHOTO-FINISH Sanoh Industrial
- CPC-NARROW A61F · 8 areas
- INNOV-PAR 48.3/100
- CLAIMS-DENSE 28.0 claims/avg
- TYPE-USCORP US Corporation
- VEL-SURGE +69% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Sanoh Industrial Co. , Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Sight’s 48.3 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Sight
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Arog Pharmaceuticals · near
Arog Pharmaceuticals · near
48 score
- Calmer Holding · near
Calmer Holding · near
48 score
- Sight Sciences · this assignee
Sight Sciences · this assignee
48 score
- Dongguan University… · near
Dongguan University… · near
48 score
- Oerlikon Textile & KG · near
Oerlikon Textile & KG · near
48 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Sight's Innovation Score is 48.3/100 (top 17% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Sight?
Each dot is one of Sight’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Sight’s own 28.0 claims/patent is ABOVE the 10.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Sight's grants concentrate
Sight Sciences, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 94% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2024 (10 grants) versus a trough of 2 in 2015. By volume, Sight sits between Scholle IPN Corporation and Sanoh Industrial Co. , Ltd..
Sight's three-year grant acceleration
Sight Sciences, Inc. shows 19 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Sight's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Scholle IPN
Scholle IPN Corporation
50 patents
- Seoyon E-hwa
Seoyon E-hwa Co., Ltd.
50 patents
- Shaanxi Lighte Op…
Shaanxi Lighte Optoelectronics Material Co., Ltd.
50 patents
- Shenzhen Heytap T…
Shenzhen Heytap Technology Corp., Ltd.
50 patents
- ST Jude Medical C…
ST. Jude Medical Coordination Center Bvba
50 patents
- Sunrex Technology
Sunrex Technology Corp.
50 patents
- Swedish Match Nor…
Swedish Match North Europe AB
50 patents
- Sanoh Industrial
Sanoh Industrial Co. , Ltd.
50 patents
- Sight Sciences ◀
Sight Sciences, Inc.
50 patents
What this shows Sight holds 50 patents at rank #6,702, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Sight
By rank, the assignees closest to #6,702 in granted patent volume.
- Scholle IPN Corporation #6,698 · 50 patents
- Seoyon E-hwa Co., Ltd. #6,699 · 50 patents
- Shaanxi Lighte Optoelectronics Material Co., Ltd. #6,700 · 50 patents
- Shenzhen Heytap Technology Corp., Ltd. #6,701 · 50 patents
- ST. Jude Medical Coordination Center Bvba #6,703 · 50 patents
- Sunrex Technology Corp. #6,704 · 50 patents
- Swedish Match North Europe AB #6,705 · 50 patents
- Sanoh Industrial Co. , Ltd. #6,706 · 50 patents
Leaders in A61F (Filters Implantable Into Blood Vessels)
Other assignees with the most granted patents in Sight's primary technology class.
- The Procter & Gamble Company 1,426 in class
- Boston Scientific Scimed, Inc. 1,101 in class
- Edwards Lifesciences Corporation 1,101 in class
- DePuy Synthes Products, Inc. 851 in class
- Globus Medical, Inc. 752 in class
- Cook Medical Technologies LLC 700 in class
- Smith & Nephew, Inc. 541 in class
- Covidien LP 528 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Sight, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Sight ranks #129 of 3,082 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (48 here).
Similar claim depth
Nearest assignees by average claims per patent (28.0 here).
Sight's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
48 Top 17% higher than 83% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 4.0% |
| 2016 | 3 | 6.0% |
| 2017 | 3 | 6.0% |
| 2018 | 3 | 6.0% |
| 2019 | 5 | 10.0% |
| 2020 | 2 | 4.0% |
| 2021 | 6 | 12.0% |
| 2022 | 7 | 14.0% |
| 2023 | 2 | 4.0% |
| 2024 | 10 | 20.0% |
| 2025partial year | 7 | 14.0% |
Which technologies does Sight Sciences, Inc. patent most?
Top 8 of 8 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Sight Sciences, Inc.'s patent record in context - here's where to go next.
- Sight Sciences, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 94% of its portfolio - see every assignee active in that class. Explore A61F
- Ranked #6,708 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Sight Sciences, Inc. against Scholle IPN Corporation, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 48.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.